Department of Pharmaceutical Sciences, UNT System College of Pharmacy, University of North Texas Health Science Center, Fort Worth, TX, USA; Graduate School of Biomedical Sciences, University of North Texas Health Science Center, Fort Worth, TX, USA.
Department of Pharmaceutical Sciences, UNT System College of Pharmacy, University of North Texas Health Science Center, Fort Worth, TX, USA.
Bioorg Med Chem Lett. 2022 Nov 15;76:129013. doi: 10.1016/j.bmcl.2022.129013. Epub 2022 Sep 29.
In this Letter we describe structure-activity relationship (SAR) studies conducted in five distinct regions of a new 2-amino-N-phenylacetamides series of Slack potassium channel inhibitors exemplified by recently disclosed high-throughput screening (HTS) hit VU0606170 (4). New analogs were screened in a thallium (Tl) flux assay in HEK-293 cells stably expressing wild-type human (WT) Slack. Selected analogs were screened in Tl flux versus A934T Slack and other Slo family members Slick and Maxi-K and evaluated in whole-cell electrophysiology (EP) assays using an automated patch clamp system. Results revealed the series to have flat SAR with significant structural modifications resulting in a loss of Slack activity. More minor changes led to compounds with Slack activity and Slo family selectivity similar to the HTS hit.
在这封信中,我们描述了对新型 2-氨基-N-苯乙酰胺 Slack 钾通道抑制剂系列中五个不同区域的结构-活性关系 (SAR) 研究,该抑制剂以最近披露的高通量筛选 (HTS) 命中物 VU0606170(4)为代表。新的类似物在稳定表达野生型人类 (WT) Slack 的 HEK-293 细胞中的铊 (Tl) 通量测定中进行筛选。选择的类似物在 Tl 通量与 A934T Slack 和其他 Slo 家族成员 Slick 和 Maxi-K 的通量中进行筛选,并使用自动化膜片钳系统在全细胞电生理学 (EP) 测定中进行评估。结果表明,该系列具有平坦的 SAR,显著的结构修饰导致 Slack 活性丧失。较小的变化导致具有 Slack 活性和 Slo 家族选择性的化合物与 HTS 命中物相似。